Compare CAR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAR | AMRX |
|---|---|---|
| Founded | 1946 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | CAR | AMRX |
|---|---|---|
| Price | $115.72 | $13.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $137.57 | $13.25 |
| AVG Volume (30 Days) | 484.1K | ★ 1.4M |
| Earning Date | 02-18-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $11,698,000,000.00 | $2,934,959,000.00 |
| Revenue This Year | $0.62 | $9.99 |
| Revenue Next Year | $1.75 | $6.48 |
| P/E Ratio | ★ N/A | $843.33 |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $54.03 | $6.69 |
| 52 Week High | $212.81 | $13.75 |
| Indicator | CAR | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.00 | 64.18 |
| Support Level | $119.34 | $13.30 |
| Resistance Level | $130.52 | $13.75 |
| Average True Range (ATR) | 4.41 | 0.33 |
| MACD | -0.52 | 0.01 |
| Stochastic Oscillator | 9.57 | 84.86 |
Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate. The majority of the company's revenue comes from the Americas.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.